1-[5-(2-Furyl)-1,3,4-oxadiazol-2-yl]-3-(2-pyridinylmethyl)urea(CAS: 1414963-82-8)

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires proper handling, storage, and disposal as per the guidelines. In the European Union, it is regulated under REACH, and in the United States, it may be subject to FDA and EPA regulations for its specific intended use.

Alternatives in synthesis often include isomers or analogs like 1-[5-(3-Furyl)-1,3,4-oxadiazol-2-yl]-3-(2-pyridinylmethyl)urea or other 1,3,4-oxadiazole derivatives. Other substitutes might involve using different functional groups or reagents to achieve similar properties while adhering to specific synthesis requirements.

The market for 1-[5-(2-Furyl)-1,3,4-oxadiazol-2-yl]-3-(2-pyridinylmethyl)urea is growing due to its potential in pharmaceutical applications, particularly as an intermediate in drug synthesis. Research trends include exploring its use in anti-inflammatory and anticancer treatments, as well as studying its biodegradability and environmental impact.

Waste containing the compound should be collected in appropriate containers, ensuring they are sealed and labeled. Disposal should be done through professional waste disposal services. Incineration is an effective method, but it must be conducted in an environmentally compliant incinerator. Additionally, proper environmental protection measures should be taken to prevent any release into the environment.